Oxford Cannabinoid Technologies Overview
- Year Founded
-
2017

- Status
-
Public
- Employees
-
12

- Stock Symbol
-
OCTHF

Oxford Cannabinoid Technologies General Information
Description
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.
Contact Information
Website
www.octavianrx.comCorporate Office
- Prama House
- 267 Banbury Road
- Oxford OX2 7HT
- England, United Kingdom
Corporate Office
- Prama House
- 267 Banbury Road
- Oxford OX2 7HT
- England, United Kingdom
Oxford Cannabinoid Technologies Stock Performance
As of 08-May-2024, Oxford Cannabinoid Technologies’s current market cap is $2.11M with 1.09B shares.
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.04 | $2.11M | 1.09B | 29.1K |
Oxford Cannabinoid Technologies Financials Summary
As of 31-Oct-2023, Oxford Cannabinoid Technologies has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 31-Oct-2023 | FY 2023 30-Apr-2023 | FY 2022 30-Apr-2022 | FY 2021 31-May-2021 |
---|---|---|---|---|
EV | (1,857) | |||
Revenue | 0 | 0 | 0 | |
EBITDA | (6,025) | (8,400) | 21 | (4,237) |
Net Income | (5,227) | (7,135) | (4,299) | |
Total Assets | 3,394 | 5,650 | 9,148 | 21,569 |
Total Debt | 0 | 0 | 0 | 247 |
Oxford Cannabinoid Technologies Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Oxford Cannabinoid Technologies Comparisons
Industry
Financing
Details
Oxford Cannabinoid Technologies Competitors (4)
One of Oxford Cannabinoid Technologies’s 4 competitors is InMed Pharmaceuticals, a Corporation company based in Vancouver, Canada.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
InMed Pharmaceuticals | Corporation | Vancouver, Canada | ||||
AXIM Biotechnologies | Corporation | New York, NY | ||||
CV Sciences | Corporation | San Diego, CA | ||||
Zynerba Pharmaceuticals | Formerly VC-backed | Plymouth, PA |
Oxford Cannabinoid Technologies Signals
Oxford Cannabinoid Technologies Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Oxford Cannabinoid Technologies FAQs
-
When was Oxford Cannabinoid Technologies founded?
Oxford Cannabinoid Technologies was founded in 2017.
-
Where is Oxford Cannabinoid Technologies headquartered?
Oxford Cannabinoid Technologies is headquartered in Oxford, United Kingdom.
-
What is the size of Oxford Cannabinoid Technologies?
Oxford Cannabinoid Technologies has 12 total employees.
-
What industry is Oxford Cannabinoid Technologies in?
Oxford Cannabinoid Technologies’s primary industry is Drug Discovery.
-
Is Oxford Cannabinoid Technologies a private or public company?
Oxford Cannabinoid Technologies is a Public company.
-
What is Oxford Cannabinoid Technologies’s stock symbol?
The ticker symbol for Oxford Cannabinoid Technologies is OCTHF.
-
What is the current market cap of Oxford Cannabinoid Technologies?
The current market capitalization of Oxford Cannabinoid Technologies is $2.11M.
-
Who are Oxford Cannabinoid Technologies’s competitors?
InMed Pharmaceuticals, AXIM Biotechnologies, CV Sciences, and Zynerba Pharmaceuticals are competitors of Oxford Cannabinoid Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »